
Contraception is For Sex
Contraception exists so that people can have sex.
That sentence is not controversial, and it is also not how we counsel. Every framework I have been trained in treats the sexual consequences of a method as a tolerability question — something to monitor, to mitigate, to raise at the appropriate point in the consultation. Bleeding profile, mood, weight, libido. The sexual life the method was built to protect is filed, quietly, under adverse effects.
We do not counsel someone on a knee replacement by listing running among the possible outcomes.
And yet something interesting is beginning to happen at the other end of the contraceptive spectrum.
For most of modern medicine, men have had remarkably few contraceptive choices. Condoms, and eventually vasectomy. In between sits a vast contraceptive landscape that women have largely been expected to navigate.
Now long-acting reversible male contraception is beginning to look less like science fiction and more like a field of research. The idea is simple enough: something a man chooses, carries and can eventually stop — contraception that is neither a condom in the moment nor a vasectomy forever.
I find the technology interesting. But I find the question it raises more interesting.
The evidence now gives this a number
A review published this year in Sexual and Reproductive Health Matters has put a figure on it. Zaneva and colleagues — a collaboration between The Pleasure Project and the World Health Organization's Department of Sexual and Reproductive Health and Research — examined 64 studies covering more than 125,000 contraceptive users. Sex-life concerns emerged as a reason for discontinuation at a prevalence comparable to cost and access: roughly one in twenty users stopping a method while still wanting to avoid pregnancy.
Their more striking finding is methodological. In the entire body of literature they searched, only two studies had directly asked participants how contraception affected their sexual lives.
Everywhere else the question was absent, or absorbed into categories such as "side effects" and "other reasons" — which in some studies accounted for as much as a third of all discontinuation.
We have been measuring this indirectly for decades and declining to name it.
The organisation asking the question

The Pleasure Project deserves an introduction, because readers outside sexual and reproductive health will not know it, and its influence on how the field now thinks is out of proportion to its size.
It was founded in 2004 by Anne Philpott, a public health specialist who noticed something obvious that the field had organised itself to ignore: the global apparatus of sexual health — condom programming, HIV prevention, contraceptive counselling, was built almost entirely around risk, disease and fear, while the reason people actually have sex went unmentioned. Their early tagline made the ambition plain: putting the sexy back into safer sex. For years this read as provocation. It has turned out to be a research programme.
In 2022, again with WHO, the Project published a meta-analysis in PLOS ONE examining fifteen years of sexual health interventions. Of some seventeen thousand studies screened, only thirty-three had incorporated pleasure at all — a finding as damning as anything in the results. Among those that had, condom use measurably improved. The interventions that acknowledged why people have sex worked better than the ones that pretended not to know.
The Lost Metric
The strongest version of the argument does not ask anyone to adopt a new value. It asks only that we take seriously something the field conceded years ago.
Every efficacy table in contraception carries two numbers: perfect use and typical use. The gap between them is an admission that a method's value depends on whether people keep using it, and that people are not compliance machines. We already accept that cost, convenience and access shape that gap. The Zaneva review establishes that sexual experience belongs on the same list.
So a pleasure-centred approach is not a soft addition to contraceptive effectiveness. It is something that affects whether contraception works in people's actual lives — something we have been capturing badly, under other names, for as long as we have had typical-use figures at all.
And pleasure here means more than orgasm or libido. It is shorthand for the whole sexual life a person wants: desire, intimacy, enjoyment, freedom from the low hum of pregnancy anxiety.
I want to be careful here, because the instrumental argument is seductive and it is not sufficient. If sexual satisfaction matters only because it improves continuation, then pleasure has become a compliance variable — a means to an endpoint that belongs to the clinician rather than the patient.
The claim I am actually making is different, and it is a philosophical one rather than an empirical one: a sexual life worth having is the outcome. Pregnancy prevention is the mechanism by which we protect it.
The Cultural Baggage of Partnership Debt
Most men who come to me for a vasectomy offer a version of the same rationale. She has been on something since she was nineteen. She has carried this long enough. It is my turn.
I like these men. The sentence is decent, and it is meant. It is also doing something we never examine, because it arrives sounding like equity and is therefore waved through.
Consider what the sacrifice framing implies. If she has been carrying contraception for him, then the good being protected all along was his access to sex without consequence, and her body was the instrument. Nobody in the room would endorse that if it were said plainly. But it is never said plainly, because the script rewards the equity line and moves on to surgical consent.
I do not think most of these men hold that view. I think they have inherited a script that encodes it, and that unasked intent gets filled in by whatever the surrounding culture supplies. Here what it supplies is a transaction — a debt between partners, settled by a procedure.

A New Paradigm
Four questions are increasingly shifting my consultation style.
"What do you want your sex life to look like on the other side of this?"
We assume the answer, often framed as pleasure without fear, and relief for his partner. Because we assume it, we never hear it said. Asking it aloud is what stops the equity script running unexamined. The pause before the answer is frequently more informative than the answer.
"What has not having to worry about pregnancy been worth to you both — and what's it cost?"
Turbulent fertility is the common case, not the edge case. Miscarriage, a pregnancy scare, infertility, a health-defining condition or obstetric adverse event that made future pregnancies dangerous. For many men this consultation is the first and only clinical setting in which anyone has asked about a pregnancy loss they were present for.
"Is there any part of you that isn't ready to close this off?"
I used to ask men whether fertility formed part of their identity, and the honest answer for most is that it does not — fertility does comparatively little identity work for a man in his forties with two children. Foreclosure is the better target. Vasectomy is chosen closure, which is usually why it lands harmlessly. The small number who hesitate here are, in my experience, the ones who return later with somatic symptoms.
"What would you want to be different about sex, if anything?"
This question is only askable within a pleasure-centred frame. A tolerability framework can ask what got worse. It cannot ask what could be better. The answers are often unrelated to the vasectomy, which is rather the point. What men name, when they name anything, maybe intimacy they want back or deepen, a hope of reconciling unresolved sexual conflicts, or a wish to explore new horizons that contraception can make possible.
I do not propose that partners routinely attend. What is more important is that both partners are part of the conversation and what both would say to the same questions. Thin or defensive answers may be reasons to slow down.

Pleasure for All
None of these are specific for men. They belong equally in the consultation where the contraceptive pill prescription is renewed for the twelfth year, or the Mirena IUD implant is due for exchange, where a woman who has been on something since she was nineteen is sitting across from her own doctor this week.
The prescriber who asks what could be better, rather than what got worse, is practising the same medicine.
None of these questions require new evidence. They require only that we stop treating sex as an afterthought and start treating it as the thing at stake.
Few people ever book an appointment to talk about sex. A contraception consultation is one of the rare moments when someone sits alone with a doctor and the subject is already open.
If contraception exists so that people can have sex, it would be a strange consultation indeed if we spent the whole appointment talking about everything except sex.
Dr Luke Wee consults in sexual and reproductive health matters to both men and women. He also provides permanent contraception for men, while being attentive to the meaning the decision carries for a couple.
First published in The Longer Consultation on LinkedIn, 11 August 2026. Cover photograph: Hannah Busing on Unsplash.